Showing results (651-660 of 1,017) with videos related to

Sort By:
Pageof 102
Molecular Pharmacology|October 23, 2002
Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanineMaida M de las Alas, Gerrit Los, Xinjian Lin, et al.
Psychiatric Services (Washington, D.C.)|April 7, 2004
Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinicsMegan V Smith, Robert A Rosenheck, Mary A Cavaleri, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
Human Pathology|March 26, 2005
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancersSharon P Wilczynski, Yuan-Yuan Chen, Wengang Chen, et al.
Journal of Paediatrics and Child Health|September 2, 2022
Response to sequential treatment with prednisolone and vigabatrin in infantile spasmsWinston Dzau, Sally Cheng, Penny Snell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 1998
Prediction-based threading of the hMSH2 DNA mismatch repair proteinM M de las Alas, R A de Bruin, L Ten Eyck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Risk of coronary heart disease and activation of factor XII in middle-aged menG J Miller, M P Esnouf, A I Burgess, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human plateletsJ A Cooper, S J Hill, S P Alexander, et al.
Science (New York, N.Y.)|January 30, 1970
Cosmogenic and primordial radionuclides in lunar samples by nondestructive gamma-ray spectrometryR W Perkins, L A Rancitelli, J A Cooper, et al.
The Pediatric Infectious Disease Journal|May 1, 1991
Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patientsG B Winnie, J A Cooper, J Witson, et al.
Pageof 102